SCYNEXIS Inc (SCYX)
2.08
-0.14
(-6.31%)
USD |
NASDAQ |
Jun 10, 16:00
2.08
0.00 (0.00%)
After-Hours: 20:00
SCYNEXIS Total Liabilities (Quarterly): 44.15M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 44.15M |
| December 31, 2023 | 55.45M |
| September 30, 2023 | 56.56M |
| June 30, 2023 | 61.78M |
| March 31, 2023 | 100.21M |
| December 31, 2022 | 84.58M |
| September 30, 2022 | 95.08M |
| June 30, 2022 | 90.13M |
| March 31, 2022 | 72.64M |
| December 31, 2021 | 78.58M |
| September 30, 2021 | 72.27M |
| June 30, 2021 | 88.81M |
| March 31, 2021 | 74.15M |
| December 31, 2020 | 79.78M |
| September 30, 2020 | 27.19M |
| June 30, 2020 | 38.93M |
| March 31, 2020 | 35.05M |
| December 31, 2019 | 44.26M |
| September 30, 2019 | 27.67M |
| June 30, 2019 | 30.67M |
| March 31, 2019 | 33.74M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.94M |
| September 30, 2018 | 23.77M |
| June 30, 2018 | 31.50M |
| March 31, 2018 | 28.64M |
| December 31, 2017 | 24.44M |
| September 30, 2017 | 22.36M |
| June 30, 2017 | 20.18M |
| March 31, 2017 | 23.12M |
| December 31, 2016 | 24.97M |
| September 30, 2016 | 27.84M |
| June 30, 2016 | 9.649M |
| March 31, 2016 | 5.637M |
| December 31, 2015 | 7.324M |
| September 30, 2015 | 6.125M |
| June 30, 2015 | 7.906M |
| March 31, 2015 | 7.419M |
| December 31, 2014 | 6.241M |
| September 30, 2014 | 5.822M |
| June 30, 2014 | 6.536M |
| March 31, 2014 | 33.40M |
| December 31, 2013 | 33.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
27.19M
Minimum
Sep 2020
100.21M
Maximum
Mar 2023
62.90M
Average
67.02M
Median
Total Liabilities (Quarterly) Benchmarks
| Bioventus Inc | 576.81M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.25M |
| Shareholders Equity (Quarterly) | 74.10M |
| Current Ratio | 3.718 |
| Net Debt Paydown Yield | 16.35% |